Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma (Annals of Surgical Oncology, (2020), 10.1245/s10434-019-08156-3)

Amr I. Al Abbas, Mazen Zenati, Caroline J. Rieser, Ahmad Hamad, Jae Pil Jung, Amer H. Zureikat, Herbert J. Zeh, Melissa E. Hogg

Research output: Contribution to journalComment/debate

Abstract

In the original article, Caroline J. Rieser’s last name is spelled wrong. It is correct as reflected here.

Original languageEnglish (US)
JournalAnnals of Surgical Oncology
DOIs
StateAccepted/In press - Jan 1 2020

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma (Annals of Surgical Oncology, (2020), 10.1245/s10434-019-08156-3)'. Together they form a unique fingerprint.

  • Cite this